Recent ENT literature by subspecialty
Selection is focused on 2024-2026 papers with a clear subspecialty focus. Most of the highly relevant recent hits are reviews or evidence syntheses, useful for rapidly mapping active research areas.
1. Otology and neurotology
- Cochlear implantation in genetically characterized sensorineural hearing loss: Fehrmann et al. (2025), Cochlear Implantation Outcomes in Genotyped Subjects with Sensorineural Hearing Loss, JARO. Observational outcomes research relevant to precision counseling and genotype-informed implantation. PMID: 40268851
- Cochlear implants for asymmetric hearing loss in older adults: Smith et al. (2025), Hearing Benefits of Cochlear Implantation in Older Adults With Asymmetric Hearing Loss, Otology & Neurotology. PMID: 40075242
- Hearing preservation after residual hearing loss in cochlear implant users: Thompson et al. (2024), Variables Affecting Cochlear Implant Performance After Loss of Residual Hearing, The Laryngoscope. PMID: 37767794
- Infant vestibular screening: Yang et al. (2025), Clinical Consensus on Vestibular Infant Screening. A Delphi consensus addressing screening targets, timing, and cVEMP protocol standardization. PMID: 41276659
Research directions: genetic stratification of cochlear implantation outcomes, expansion of adult CI candidacy, hearing preservation, and early vestibular assessment.
2. Rhinology and anterior skull base
- Systematic review . Tier 1: Monos et al. (2024), Predicting Adherence to Topical Medications in Chronic Rhinologic Disease, Otolaryngology-Head and Neck Surgery. Relevant to a major determinant of medical and postoperative CRS outcomes. PMID: 38822756
- Systematic review . Tier 1: Huang et al. (2025), Bibliometric Analysis of Biologic Treatments for Chronic Rhinosinusitis, Frontiers in Medicine. Maps the expanding biologics literature in CRSwNP. PMID: 40861204
- Review . Tier 7: Jin et al. (2025), Biological Therapy in Chronic Rhinosinusitis With Nasal Polyps, Expert Review of Clinical Immunology. PMID: 39862235
- Review . Tier 7: Boyd and Khanwalkar (2024), Biologics in Chronic Rhinosinusitis: Current and Emerging, Immunology and Allergy Clinics of North America. PMID: 39389716
Research directions: selection and sequencing of biologics, biomarkers for treatment response, topical-therapy adherence, and disease-control measures beyond polyp score.
3. Head and neck oncology
- Systematic review . Tier 1: Shen and He (2026), Advancements in Immunotherapy for Oropharyngeal Cancer: Current Landscape and Future Prospects. Focuses on checkpoint inhibitors, HPV-related disease, and cancer-vaccine approaches. PMID: 40827652
- Translational research: Cha et al. (2024), Single-Cell Analysis Reveals Cellular and Molecular Factors Counteracting HPV-Positive Oropharyngeal Cancer Immunotherapy Outcomes, Journal for ImmunoTherapy of Cancer. PMID: 38857913
- Review . Tier 7: Razavian (2025), Advances in Systemic and Immunotherapies for Human Papillomavirus-Mediated Oropharyngeal Cancers, Cancer Journal. PMID: 40459978
- Broad clinical review: Dunn, Ho, and Pfister (2026), Head and Neck Cancer: A Review, JAMA. PMID: 41396597
Research directions: predictive immune biomarkers, de-escalation in HPV-associated oropharyngeal carcinoma, personalized systemic therapy, and tumor-microenvironment profiling.
4. Laryngology, voice, and airway
- Review . Tier 7: Szalenko-Tőkés et al. (2025), Injection Laryngoplasty for the Treatment of Unilateral Vocal Fold Paralysis. Covers contemporary injectable approaches and outcome considerations. PMID: 40581924
- Practice-pattern research: Yam et al. (2026), Prevalence of Objective Voice Measurement Use in Laryngology Practices in the United States, Journal of Voice. PMID: 37980207
- Clinical review: Hartley and Hartley (2025), Management of Bilateral Vocal Fold Paralysis in Children, Current Opinion in Otolaryngology & Head and Neck Surgery. PMID: 40836783
- Pediatric review: Kiessling and Sidell (2026), Pediatric Vocal Fold Paralysis, Otolaryngologic Clinics of North America. PMID: 42014211
Research directions: objective and patient-reported voice metrics, timing and durability of injection laryngoplasty, pediatric airway reconstruction, and nerve-reinnervation strategies.
5. Pediatric ENT and sleep surgery
- Review . Tier 7: Lele et al. (2025), An Overview of Management Strategies for Pediatric Obstructive Sleep Apnea Following Adenotonsillectomy. Addresses persistent OSA after first-line surgery. PMID: 40338224
- Perioperative review: Penberthy and Dalesio (2025), Perioperative Management of Pediatric Patients With Obstructive Sleep Apnea Syndrome Presenting for Adenotonsillectomy. PMID: 40241421
- Review . Tier 7: Jaensch et al. (2024), Adenotonsillectomy for Obstructive Sleep Apnea in Children, Otolaryngologic Clinics of North America. PMID: 38575485
- Pediatric airway case research: Endoscopic Aryepiglottic Z-Plasty for Pediatric Post-Supraglottoplasty Supraglottic Stenosis (2025). A report of a mucosa-sparing approach to a complex postoperative airway complication. PMID: 40948443
Research directions: persistent OSA phenotyping after adenotonsillectomy, obesity-associated surgical outcomes, perioperative risk stratification, DISE-guided surgery, and complex endoscopic airway reconstruction.
Cross-cutting emerging themes
- Precision ENT: use of genomics, single-cell profiling, and biomarkers to predict treatment response.
- Biologics and immunotherapy: especially CRSwNP and HPV-associated head and neck cancer.
- Outcome measurement: stronger interest in validated patient-reported outcomes and objective voice, hearing, and sleep metrics.
- Minimally invasive intervention: endoscopic airway techniques, advances in cochlear implantation, and tailored surgical decision-making.
- Equity and implementation: adherence, access to biologics and implants, and variation in practice are receiving greater attention.
These citations are a current reading shortlist, not a systematic review. For journal-club use, prioritize the systematic reviews and the single-cell HPV-positive oropharyngeal cancer paper, then narrow by the clinical question.